Although much more research will be needed, treatment with recombinant protein C could offer a new way of interrupting the progression to sepsis and organ failure in high-risk patients.

• 尽管还需进行更多的研究，但对高风险患者应用重组蛋白C进行治疗为阻断败毒症和器官衰竭的进展提供了新的途径。